330883 RESULTS
COMMENT Reply to comment by Sam Gandy and John Steele I appreciate the interest in intraneuronal Aβ by Gandy and Steele, who have been contributing to this topic. I also welcome the comment, because interaction and questioning is so important. Yes, it has been a
COMMENT This manuscript describes in detail the postmortem assessment of an AD patient studied twice with PIB-PET and three times with FDG-PET during life (last PIB 35 months before death). The subject happens to be the first patient ever studied with PIB-PET, an
COMMENT This case report study of the first Pittsburgh Compound B (PIB) positron emission tomography patient with Alzheimer’s disease (AD) by Kadir et al. provides extensive descriptive information regarding the neuropathological changes found in the brain of a 6
COMMENT We thank Rakez for his comment. Antibody response towards non-phosphorylated regions of the immunogen can be expected considering its length and immunogenicity. This should not cause major concerns, as we address in the fourth paragraph of the Discussion
COMMENT This is interesting, especially the viral genome theories. References: Martin. subrosa3 0
COMMENT Prion-like behavior of amyloid-β or corticosterone-induced cerebral β-amyloidosis? Eisele and colleagues (1) reported increased cerebral amyloidosis in amyloid precursor protein (APP) transgenic (tg) mice after intraperitoneal inoculation with β-amyloid-r
PAPER Rivest S
COMMENT Those working and playing with Mark had a special knowledge, the secret of his superhuman power to get things done. It was simple: generosity of spirit, intellect and effort, all hidden under a legendary sense of humor and love of life. Mark supported eve
ANTIBODY polyclonal manufacturer Cat# sc-11420<br />Reference: <br /><a href="/papers/acetylation-tau-inhibits-its-degradation-and-contributes-tauopathy" target="_new">Min SW, 2010</a> immunogen = epitope corresp. to aa
RESEARCH NEWS 2010-12-28 Research News Imaging techniques promise to revolutionize the diagnosis of Alzheimer’s and other neurodegenerative diseases, but at this point, data on how live images correlate with pathological brain changes are still limited. In the December 13 Brain,
COMMENT I came to Mark’s lab as a Fulbright scholar in the fall of 2007 from a small EU country, Serbia. In the first week of my stay in Mark's lab, he challenged me to work on a hypothesis that was at the time and is still now a new paradigm of how neuronal
COMMENT This is a terrible loss to the field. Mark was a much-needed counter voice against the most popular theories and models of AD. He will be missed. mpmurp3 0
COMMENT Thank God for CAMD and this scientific forum. There are just too many uncounted deaths like my father's last month. He passed from liver cancer according to his death certificate, but he was in middle stage of Alzheimer's and therefore not a can
COMMENT So sorry to hear this tragic news. Losing someone who was doing their best to make a contribution to find answers to this devastating disease is a tragedy. sby2k 0
United States
No filters selected
